Oil prices dip on OPEC+ hike speculation; US inventories seen rising
Investing.com - Goldman Sachs downgraded China Feihe Limited (HK:6186) (OTC:CFEIY) from Buy to Neutral and slashed its price target to HK$4.30 from HK$6.40, citing weaker-than-expected infant milk formula product volume growth.
The investment bank revised down Feihe’s topline estimates by 9.9%-10.8% for 2025-2027 and expects a gross profit loss of approximately 800 million yuan for other dairy products on dry milk powder resale amid excessive raw milk supply.
Goldman Sachs cut its earnings estimates for the Chinese dairy company by 20.0%-30.2% and recurring net profit estimates by 19%-26.9% for 2025-2027, considering larger non-operating expenses including biological asset impairment in 2025, though it expects this trend to decrease going forward.
The firm now forecasts approximately 2.0 billion yuan in reported net profit and 2.7 billion yuan in recurring net profit for China Feihe, with competition dynamics remaining the main concern for topline and bottom line performance into the second half of the year.
Goldman’s new price target of HK$4.30 represents a 2% downside potential and reflects both the earnings cut and a reduced target price-to-earnings multiple of 12x 2026 estimated earnings, down from the previous 13.5x, based on Feihe’s 2020-2025 year-to-date average PE ratio.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.